1,2-benzoxazol-3-ylmethanesulfonamide

• Product Name1,2-benzoxazol-3-ylmethanesulfonamide
  CAS No.68291-97-4
  Purity99.5%
  Min Quantity300Kilograms
  Price~
• View Contact Detail

• 
  Molecular Structure

Detailed Description

Synonyms: 1-(1,2-Benzoxazol-3-yl)methanesulphonamide

Main Specifications:

Appearance: white crystalline powder

Assay: 99% Min. HPLC

Single Impurity: 0.5% Max.

Loss on Drying: 0.5% Max.

Heavy Metal: 20ppm Max.

Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunct therapy in adults with partial-onset seizures. Zonisamide is approved in the United States, United Kingdom, China, for adjunctive treatment of partial seizures in adults and in Japan for both adjunctive and monotherapy for partial seizures (simple,complex, secondarily generalized), generalized (tonic, tonic-clonic(grand mal), and atypical absence) and combined seizures.
• 
• 1,2-benzoxazol-3-ylmethanesulfonamide